Mahmoud Mahmoudian, PhD. FRSC

Current

• Vaccines & Biologics at Merck & Co. USA

Past

• Biotechnology: Global Director R&D, Alliances & Partnerships at Rohm & Haas Biotech, USA
• Biotechnology: Worldwide Head R&D, Strategic Alliances at Eastman Biotech, USA
• Biopharma, Preclinical Development at GlaxoSmithKline, UK

• Biotechnology: Senior Research Fellow at ICI BioProducts (Avecia, AstraZeneca), UK

see less...

1 more...

Education

• University of Pennsylvania - The Wharton School
• Imperial College London

Recommended

1 person has recommended Mahmoud

Connections

175 connections

Industry

Pharmaceuticals

Mahmoud Mahmoudian, PhD. FRSC’s Summary

Venture Capitals: Advisor to life sciences venture funds in Philadelphia and Boston consulting on business plans, market and technology assessments, resulting in investment opportunities in several early to mid-stage biotech companies.

Merck & Co. USA (2007 – present): Responsible for Merck's strategic sourcing and partnerships in vaccines, biologics and Merck BioVenture on a global basis.

Established two biosciences business ventures, at Eastman and Rohm & Haas (2002 – 2007), via partnerships, licensing deals, and joint ventures including Genencor and Sanofi-Aventis. Member of the CEO team that recommended the divestiture of Genencor to Danisco for $475m.

GlaxoSmithKline UK (1989 – 2002): Principal Investigator in the discovery, research and development of six blockbusters with combined annual sales of $15 billion, including Lamuvidine (anti-hepatitis), Epivir (anti-HIV), Abacavir (anti-HIV), Relenza (anti-flu), Zygara (anti-leukaemic) and tribactam antibiotics (infectious diseases).

Mahmoud Mahmoudian, PhD. FRSC’s Specialties:

Business Development Leader with expertise in pharma, biotech and biopharma strategic alliances, external research, due diligence, deal negotiations, licensing, alliance management, marketing, portfolio/ project management and corporate strategy. Extensive technical expertise in drug discovery, preclinical development, manufacturing, operations, production of pharmaceuticals, vaccines, biologics, therapeutic proteins with an international biotech network/ consultancy background in life sciences.

Mahmoud Mahmoudian, PhD. FRSC’s Experience

• Vaccines & Biologics

  Merck & Co. USA

  (Public Company; MRK; Pharmaceuticals industry)

  2007 — Present (2 years)

  Strategic sourcing and partnerships in vaccines and biologics. Recipient of Merck Award of Excellence for leadership and business acumen (2008).

• Biotechnology: Global Director R&D, Alliances & Partnerships

  Rohm & Haas Biotech, USA

  (Chemicals industry)

  2005 — 2007 (2 years)

  Established a new corporate biosciences growth initiative, directing the strategic alliances and research functions in five R&D centres globally (USA, UK, France, China, Japan), covering a diverse portfolio. Initiated negotiations with six partners including Genzyme, closing two deals within 12 months, in a $2 billion market space. Member of 1) corporate growth team for healthcare, 2) Technical Council and 3) Emerging Technology Board of Directors reviewing new technologies, corporate funding and strategies.

• Biotechnology: Worldwide Head R&D, Strategic Alliances

  Eastman Biotech, USA

  (Chemicals industry)

  2002 — 2005 (3 years)

  Member of corporate Biotechnology Board of Directors. Established a new corporate biotech business venture, Eastman Biotech a unit of Eastman Chemical Company, within three years of inception. Responsible for strategic alliances, R&D, growth and development of a BioProduct portfolio through external alliances in a $500m market.

• Biopharma, Preclinical Development

  GlaxoSmithKline, UK

  (Public Company; GSK; Pharmaceuticals industry)

  1989 — 2002 (13 years)

  Biotech, Biopharma, Drug Discovery, Preclinical R&D:
  
  Extensive experience in 1) discovery research and preclinical drug development (emerging technologies, lead optimization, high throughput screening, combinatorial biosynthesis, drug metabolism, natural products, fermentation, enzyme & microbial technologies, biocatalysis, bioprocessing), 2) chemical development for scale up and technology transfer to global bio-manufacturing sites, and 3) key strategic alliances in several disease areas (oncology, CNS, anti-viral, infectious diseases) for production of therapeutic proteins and chiral pharmaceuticals (API).

• Biotechnology: Senior Research Fellow

  ICI BioProducts (Avecia, AstraZeneca), UK

  (Pharmaceuticals industry)

  1984 — 1989 (5 years)

  Senior Research Fellow, BioProducts.

Mahmoud Mahmoudian, PhD. FRSC’s Education

• University of Pennsylvania - The Wharton School

  Executive Strategic Marketing 2006 — 2007

• Imperial College London

  MSc, PhD , Biotechnology , 1985 — 1989

  Scholarship from ICI BioProducts (Avecia, AstraZeneca)

Additional Information

Mahmoud Mahmoudian, PhD. FRSC’s Groups:

Licensing Executive Society USA; Business Development Institute USA; Private Equity & Venture Capital Group USA; Biotechnology Industry Organization (BIO) USA; Greater Philadelphia Senior Executive Group USA; Pharmaceutical Consulting Consortium Inc. USA; Industrial Research Institute USA; The Life Science Executive Exchange USA; Asia-Pacific Pharmaceutical Industry Professionals USA.

•    Wharton Technology and Technology VC Network
•    Greater Philadelphia Senior Executive Group
•    Renewable Energy Business Network
•    Global Sourcing
•    Licensing Executives Society (U.S.A. and Canada), Inc. (LES US/C)
•    Global Private Equity & Venture Capital
•    New York Venture Community
•    Biotech & Pharma Professionals Network
•    Mid-Atlantic Bio
•    Japan Biotech Network
•    The Life Science Executive Exchange
•    The Global Business Development Network
•    Business Development Institute (BDI)
•    Merck and Co. Network
•    GSK Employees and Alumni Network
•    Biotech Investment Group
•    BioNJ
•    Global Healthcare
•    Pharmaceutical Consulting Consortium, Inc. (PCCI)
•    Biotechnology Industry Organization

Mahmoud Mahmoudian, PhD. FRSC’s Honors:

Advisory Boards:

Board member European Federation on Biotechnology, European Union (2008)

Serving on the International Editorial Advisory Board of 7 scientific journals (1999 – present)

Government advisory panels. Advisor for evaluating research proposals, allocating funding to universities and institutions throughout Britain (1995 – 2000)

FRSC. Fellow of the Royal Society of Chemistry, England (2001)
_________________________________

Mahmoud Mahmoudian, PhD, FRSC
Pennsylvania, PA, USA
mm6382@yahoo.co.uk